von Voss Liv, Arora Tulika, Assis Juliana, Kuentzel Katharina B, Arfelt Kristine N, Nøhr Mark K, Grevengoed Trisha J, Arumugam Manimozhiyan, Mandrup-Poulsen Thomas, Rosenkilde Mette M
Molecular and Translational Pharmacology, Department of Biomedical Sciences, University of Copenhagen, DK 2200 Copenhagen, Denmark.
Novo Nordisk Foundation Center for Basic Metabolic Research and Medical Sciences, University of Copenhagen, DK 2200 Copenhagen, Denmark.
J Endocr Soc. 2024 Oct 29;8(12):bvae188. doi: 10.1210/jendso/bvae188.
Excessive eating and intake of a Western diet negatively affect the intestinal immune system, resulting in compromised glucose homeostasis and lower gut bacterial diversity. The G protein-coupled receptor GPR183 regulates immune cell migration and intestinal immune response and has been associated with tuberculosis, type 1 diabetes, and inflammatory bowel diseases.
We hypothesized that with these implications, GPR183 has an important immunometabolic role and investigated this using a global Gpr183 knockout mouse model.
Wild-type (WT) and -deficient (Gpr183) mice were fed a high-fat, high-sucrose diet (HFSD) for 15 weeks. We investigated changes in weight, body composition, fecal immunoglobulin A (IgA) levels, fecal microbiome, and glucose tolerance before and after the diet. Macrophage infiltration into visceral fat was determined by flow cytometry, and hepatic gene expression was measured.
A sexual dimorphism was discovered, whereby female Gpr183 mice showed adverse metabolic outcomes compared to WT counterparts with inferior glucose tolerance, lower fecal IgA levels, and increased macrophage infiltration in visceral fat. In contrast, male Gpr183 mice had significantly lower fasting blood glucose after diet than male WT mice. Liver gene expression showed reduced inflammation and macrophage markers in Gpr183 livers, regardless of sex, while the pancreatic islet area did not differ between the groups. No conclusive differences were found after microbiome sequencing.
Gpr183 maintains metabolic homeostasis in female but not in male mice independent of diet. If confirmed in humans, future therapy targeting GPR183 should consider this sexual dimorphism.
过度进食和西方饮食摄入会对肠道免疫系统产生负面影响,导致葡萄糖稳态受损和肠道细菌多样性降低。G蛋白偶联受体GPR183调节免疫细胞迁移和肠道免疫反应,并与结核病、1型糖尿病和炎症性肠病有关。
鉴于这些影响,我们假设GPR183具有重要的免疫代谢作用,并使用全球Gpr183基因敲除小鼠模型对此进行了研究。
将野生型(WT)和基因缺陷型(Gpr183)小鼠喂食高脂高糖饮食(HFSD)15周。我们研究了饮食前后体重、身体成分、粪便免疫球蛋白A(IgA)水平、粪便微生物群和葡萄糖耐量的变化。通过流式细胞术测定巨噬细胞向内脏脂肪的浸润情况,并测量肝脏基因表达。
发现了一种性别差异,即与野生型对照相比,雌性Gpr183小鼠表现出不良的代谢结果,葡萄糖耐量较差,粪便IgA水平较低,内脏脂肪中的巨噬细胞浸润增加。相比之下,雄性Gpr183小鼠饮食后的空腹血糖明显低于雄性野生型小鼠。肝脏基因表达显示,无论性别如何,Gpr183肝脏中的炎症和巨噬细胞标志物均减少,而两组之间的胰岛面积没有差异。微生物群测序后未发现确凿差异。
Gpr183在雌性而非雄性小鼠中维持代谢稳态,且与饮食无关。如果在人类中得到证实,未来针对GPR183的治疗应考虑这种性别差异。